Collaborative Neuroscience Network, LLC
Long Beach 2600 Redondo Avenue, Suite 500, Long Beach, CA 90806 MAP
Orange County 12772 Valley View St., Suite 3, Garden Grove, CA 92845 MAP
South Bay 19401 S. Vermont Avenue, Suite F-100, Torrance, CA 90502 MAP
Founded in 2000, Collaborative Neuroscience Network (CNS) has grown to become one of the largest clinical research providers in the country, and the largest in Southern California. CNS has extensive experience in psychiatry, neurology, general medical, healthy subject, and early phase trials.
CNS operates three outpatient clinics located in Garden Grove, Long Beach, and Torrance. Additionally, its Long Beach facility offers a JCAHO-accredited Psychiatric Health Facility (PHF) and a Clinical Pharmacology Unit (CPU) specially designed for early phase research.
CNS offers an outstanding team of experts who oversee the setup and conduct of each clinical study. Dr. David Walling, CEO and Principal Investigator, has participated as a lead or co-investigator in hundreds of Phase I-IV clinical studies, with many focusing on schizophrenia, an indication for which he has KOL status. He has extensive experience advising leading pharmaceutical sponsors in the design and analysis of clinical trials in all phases. Dr. Larry Ereshefsky, CSO, Early Phase Development, is an internationally recognized thought leader in clinical translational central nervous system research. Under their leadership, CNS is well-positioned to provide the scientific guidance and operational expertise needed to ensure the success of its clinical research.
CNS has a long history of consistent subject recruitment and retention. With locations in ethnically diverse metropolitan areas, a subject database with 90,000 individuals, and an experienced dedicated recruitment staff comprised of 20+ outreach and recruitment specialists, CNS is well-positioned to meet enrollment goals within timelines.
In 2010, CNS welcomed the addition of Pacific Research Partners, a Northern California division in Oakland.
Download the CNS fact sheet.
Clinical Pharmacology Unit (CPU)
Collaborative Neuroscience Network’s Early Phase research facility is centrally located in the Los Angeles metropolitan market less than 1/4 mile from the Long Beach Airport.
- 40,000 sq ft state-of-the-art facility specially designed for early phase research
- Phase I unit with 60+ beds for healthy subjects and stable patients
- Licensed and JCAHO Accredited Psychiatric Health Facility (PHF) with 30 beds
Download the CPU fact sheet.
Download a presentation about the CPU.
David Walling, PhD, CEO, Principal Investigator. Licensed Clinical Psychologist.
Larry Ereshefsky, PharmD, CSO, Early Phase Development. Internationally recognized thought leader in clinical translational central nervous system research.
Armen Goenjian, MD, CMO, Principal Investigator. Board Certified Psychiatrist.
Mark Leibowitz, MD, Medical Director of Early Phase Research, Principal Investigator. Board Certified Internist.
Omid Omidvar, MD, Principal Investigator. Board Certified Neurologist.
Steven Reynolds, DO, Principal Investigator. Board Certified Family Practitioner.
Nirav Patel, MD, Principal Investigator. Board Certified Neurologist.
Lara Shirikjian, DO, Principal Investigator. Board Certified Psychiatrist.